Skip to main content

Want a detailed portfolio tracker?

Amicus Therapeutics (FOLD) P/E (2011 - 2026)

Amicus Therapeutics (FOLD) P/E from Mar 31, 2011 to Apr 27, 2026. The TTM Amicus Therapeutics (FOLD) P/E is -164.36. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Amicus Therapeutics (FOLD)

YearP/EChange
2026-164.36+1.76%
2025-161.52+225.27%
2024-49.66+113.62%
2023-23.25+79.55%
2022-12.95+2.91%
2021-12.58-41.82%
2020-21.62+221.64%
2019-6.72+29.54%
2018-5.19-34.84%
2017-7.97+124.33%
2016-3.55-58.72%
2015-8.60-59.95%
2014-21.48+953.28%
2013-2.04-22.67%
2012-2.64-20.76%
2011-3.33N/A

Comparison Amicus Therapeutics (FOLD) P/E with competitors

Amicus Therapeutics (FOLD) P/E is -164.36.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-100.06%
ENLVEnlivex Therapeutics Ltd0.15-100.09%
FGENFibroGen Inc0.24-100.15%
TRAWTraws Pharma Inc0.47-100.29%
FBIOFortress Biotech Inc0.71-100.43%
CHRSCoherus Biosciences Inc0.98-100.60%
ORMPOramed Pharmaceuticals Inc1.47-100.90%
AGENAgenus Inc2.05-101.25%
VIVSVivoSim Labs Inc2.54-101.54%
INVAInnoviva Inc3.19-101.94%
CRMDCorMedix Inc3.65-102.22%
ABEOAbeona Therapeutics Inc4.20-102.56%
VXRTVaxart Inc4.26-102.59%
CVACCureVac N.V.4.45-102.70%
SRPTSarepta Therapeutics Inc4.62-102.81%
GLPGGalapagos NV4.86-102.96%
RIGLRigel Pharmaceuticals4.92-102.99%
ZVRAZevra Therapeutics Inc4.97-103.03%
ABUSArbutus Biopharma Corp5.69-103.46%
CGENCompugen Ltd7.38-104.49%
AUPHAurinia Pharmaceuticals Inc9.25-105.63%
ACADAcadia Pharmaceuticals Inc9.59-105.83%
OMEROmeros Corporation9.88-106.01%
PLXProtalix BioTherapeutics Inc9.91-106.03%
SPROSpero Therapeutics Inc10.73-106.53%
ADMAAdma Biologics Inc11.33-106.89%
SVASinovac Biotech Ltd11.44-106.96%
TBPHTheravance Biopharma Inc11.78-107.17%
HRMYHarmony Biosciences Holdings Inc12.18-107.41%
TGTXTG Therapeutics Inc13.18-108.02%
INCYIncyte Corp13.38-108.14%
SABSSAB Biotherapeutics Inc14.06-108.55%
XOMAXOMA Corp14.95-109.09%
REGNRegeneron Pharmaceuticals Inc14.98-109.11%
PBYIPuma Biotechnology Inc15.05-109.16%
EXELExelixis Inc15.79-109.61%
NAGENiagen Bioscience Inc16.35-109.95%
CPRXCatalyst Pharmaceuticals Inc17.34-110.55%
MDXGMimedx Group Inc17.38-110.57%
ARGXArgen X SE23.07-114.04%
HALOHalozyme Therapeutics Inc23.20-114.12%
XOMAOXOMA Corp25.34-115.42%
VRTXVertex Pharmaceuticals Inc25.66-115.61%
XOMAPXOMA Corp25.67-115.62%
CTMXCytomX Therapeutics Inc25.70-115.64%
ASNDAscendis Pharma A/S26.35-116.03%
RPRXRoyalty Pharma plc - Class A27.50-116.73%
SLNOSoleno Therapeutics Inc29.02-117.65%
LGNDLigand Pharmaceuticals Inc - Class B30.19-118.37%
BMRNBiomarin Pharmaceutical Inc37.51-122.82%
APLSApellis Pharmaceuticals Inc39.02-123.74%
KRYSKrystal Biotech Inc39.70-124.15%
GMABGenmab40.20-124.46%
ONCBeiGene Ltd67.03-140.78%
TECHBio-Techne Corp68.59-141.74%
VCELVericel Corp80.63-149.06%
PHARPharming Group N.V.87.74-153.38%
ALNYAlnylam Pharmaceuticals Inc124.93-176.01%
TLXTelix Pharmaceuticals Ltd139.89-185.11%
CORTCorcept Therapeutics Inc158.39-196.37%